

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.55310401 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.29637686 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.21472452 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.66978188 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.57988743 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.57988743 |
| 7 | type I interferon signaling pathway (GO:0060337) | 5.55744774 |
| 8 | cellular response to type I interferon (GO:0071357) | 5.55744774 |
| 9 | response to type I interferon (GO:0034340) | 5.53022751 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.36566853 |
| 11 | detection of bacterium (GO:0016045) | 4.94980760 |
| 12 | detection of other organism (GO:0098543) | 4.78281635 |
| 13 | vocalization behavior (GO:0071625) | 4.66939850 |
| 14 | regulation of bile acid biosynthetic process (GO:0070857) | 4.58879907 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.42574473 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.42574473 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.42574473 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.42574473 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.42574473 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.42574473 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 4.33488236 |
| 22 | leukocyte aggregation (GO:0070486) | 4.32390729 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.25268192 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.24715670 |
| 25 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.24387184 |
| 26 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.22815279 |
| 27 | neuromuscular process controlling posture (GO:0050884) | 4.19191363 |
| 28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.19159462 |
| 29 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.14104536 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.12211023 |
| 31 | response to interferon-alpha (GO:0035455) | 4.09179611 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 3.99950275 |
| 33 | response to peptidoglycan (GO:0032494) | 3.98923191 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.96630527 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.94990179 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.89008954 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.86142796 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.85617577 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.83893724 |
| 40 | intestinal absorption (GO:0050892) | 3.82359299 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.79753140 |
| 42 | glutamate receptor signaling pathway (GO:0007215) | 3.75439776 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 3.74526377 |
| 44 | response to interferon-beta (GO:0035456) | 3.72479468 |
| 45 | negative thymic T cell selection (GO:0045060) | 3.71084137 |
| 46 | cerebellar granule cell differentiation (GO:0021707) | 3.69292101 |
| 47 | T cell migration (GO:0072678) | 3.63479505 |
| 48 | regulation of T cell tolerance induction (GO:0002664) | 3.61603443 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.58907389 |
| 50 | response to interleukin-15 (GO:0070672) | 3.58905574 |
| 51 | L-phenylalanine catabolic process (GO:0006559) | 3.58182562 |
| 52 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.58182562 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.55899744 |
| 54 | negative T cell selection (GO:0043383) | 3.55687011 |
| 55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.54610525 |
| 56 | negative regulation of viral genome replication (GO:0045071) | 3.54186946 |
| 57 | thymic T cell selection (GO:0045061) | 3.50229077 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48906855 |
| 59 | positive thymic T cell selection (GO:0045059) | 3.43685132 |
| 60 | germinal center formation (GO:0002467) | 3.42342851 |
| 61 | phospholipid efflux (GO:0033700) | 3.42323573 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.41968913 |
| 63 | cellular response to interleukin-15 (GO:0071350) | 3.39877629 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.38156732 |
| 65 | L-phenylalanine metabolic process (GO:0006558) | 3.38156732 |
| 66 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.38131769 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 3.37382185 |
| 68 | tolerance induction (GO:0002507) | 3.36147535 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.36123102 |
| 70 | response to host immune response (GO:0052572) | 3.36123102 |
| 71 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.35451922 |
| 72 | B cell mediated immunity (GO:0019724) | 3.34884470 |
| 73 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.34882258 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.34663284 |
| 75 | locomotory exploration behavior (GO:0035641) | 3.33666335 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29876613 |
| 77 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.26695370 |
| 78 | long-term memory (GO:0007616) | 3.26654431 |
| 79 | response to host (GO:0075136) | 3.25097477 |
| 80 | response to host defenses (GO:0052200) | 3.25097477 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.25097477 |
| 82 | B cell receptor signaling pathway (GO:0050853) | 3.24195821 |
| 83 | T cell selection (GO:0045058) | 3.23289240 |
| 84 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.23136664 |
| 85 | regulation of tolerance induction (GO:0002643) | 3.22204974 |
| 86 | cholesterol efflux (GO:0033344) | 3.17461055 |
| 87 | exploration behavior (GO:0035640) | 3.17460374 |
| 88 | high-density lipoprotein particle remodeling (GO:0034375) | 3.16823425 |
| 89 | regulation of triglyceride catabolic process (GO:0010896) | 3.16475049 |
| 90 | synaptic transmission, glutamatergic (GO:0035249) | 3.15814263 |
| 91 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.14774768 |
| 92 | regulation of cholesterol esterification (GO:0010872) | 3.14311615 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 3.13544533 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 3.12476952 |
| 95 | positive regulation of antigen processing and presentation (GO:0002579) | 3.12126791 |
| 96 | urea metabolic process (GO:0019627) | 3.11833125 |
| 97 | urea cycle (GO:0000050) | 3.11833125 |
| 98 | detection of biotic stimulus (GO:0009595) | 3.11663045 |
| 99 | synaptic vesicle maturation (GO:0016188) | 3.11565111 |
| 100 | drug catabolic process (GO:0042737) | 3.11374066 |
| 101 | gamma-aminobutyric acid transport (GO:0015812) | 3.10472667 |
| 102 | cellular extravasation (GO:0045123) | 3.09830970 |
| 103 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.09221388 |
| 104 | negative regulation of innate immune response (GO:0045824) | 3.08800495 |
| 105 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.08779405 |
| 106 | synaptic vesicle exocytosis (GO:0016079) | 3.08769858 |
| 107 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.07921506 |
| 108 | defense response to protozoan (GO:0042832) | 3.03782294 |
| 109 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.03762566 |
| 110 | nucleobase catabolic process (GO:0046113) | 3.02265846 |
| 111 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01766943 |
| 112 | respiratory burst (GO:0045730) | 3.01717272 |
| 113 | positive regulation of B cell differentiation (GO:0045579) | 3.01490223 |
| 114 | aromatic amino acid family catabolic process (GO:0009074) | 3.00805819 |
| 115 | cell differentiation in hindbrain (GO:0021533) | 3.00208569 |
| 116 | regulation of B cell differentiation (GO:0045577) | 3.00195331 |
| 117 | cellular response to interferon-gamma (GO:0071346) | 2.98848384 |
| 118 | glutamate secretion (GO:0014047) | 2.98240374 |
| 119 | lymphocyte chemotaxis (GO:0048247) | 2.97306148 |
| 120 | neuronal action potential propagation (GO:0019227) | 2.96266495 |
| 121 | regulation of mast cell degranulation (GO:0043304) | 2.95768498 |
| 122 | dendritic spine morphogenesis (GO:0060997) | 2.95763923 |
| 123 | negative regulation of phagocytosis (GO:0050765) | 2.95573861 |
| 124 | positive regulation of type 2 immune response (GO:0002830) | 2.95464122 |
| 125 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.94328633 |
| 126 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.94299020 |
| 127 | neurotransmitter secretion (GO:0007269) | 2.93615097 |
| 128 | reverse cholesterol transport (GO:0043691) | 2.93008765 |
| 129 | cellular potassium ion homeostasis (GO:0030007) | 2.92965730 |
| 130 | myeloid cell activation involved in immune response (GO:0002275) | 2.92312680 |
| 131 | plasma lipoprotein particle assembly (GO:0034377) | 2.92227816 |
| 132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91126586 |
| 133 | bile acid biosynthetic process (GO:0006699) | 2.91004243 |
| 134 | cellular response to interferon-alpha (GO:0035457) | 2.90296469 |
| 135 | regulation of interferon-alpha production (GO:0032647) | 2.90050584 |
| 136 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89470820 |
| 137 | protein-lipid complex remodeling (GO:0034368) | 2.89470820 |
| 138 | macromolecular complex remodeling (GO:0034367) | 2.89470820 |
| 139 | regulation of regulatory T cell differentiation (GO:0045589) | 2.88674661 |
| 140 | sodium ion export (GO:0071436) | 2.87728915 |
| 141 | kynurenine metabolic process (GO:0070189) | 2.87313898 |
| 142 | lymphocyte migration (GO:0072676) | 2.86930444 |
| 143 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86859019 |
| 144 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86037931 |
| 145 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86037931 |
| 146 | angiotensin maturation (GO:0002003) | 2.84656447 |
| 147 | response to protozoan (GO:0001562) | 2.83993627 |
| 148 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83866728 |
| 149 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83166135 |
| 150 | negative regulation of type 2 immune response (GO:0002829) | 2.81691257 |
| 151 | response to interferon-gamma (GO:0034341) | 2.80230030 |
| 152 | cellular response to interferon-beta (GO:0035458) | 2.79675513 |
| 153 | positive T cell selection (GO:0043368) | 2.79142825 |
| 154 | neuron-neuron synaptic transmission (GO:0007270) | 2.78778512 |
| 155 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77702049 |
| 156 | negative regulation of sterol transport (GO:0032372) | 2.77065465 |
| 157 | negative regulation of cholesterol transport (GO:0032375) | 2.77065465 |
| 158 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.77045926 |
| 159 | protein-lipid complex assembly (GO:0065005) | 2.76275674 |
| 160 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.75112869 |
| 161 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.74970353 |
| 162 | nitrogen cycle metabolic process (GO:0071941) | 2.74645008 |
| 163 | cellular sodium ion homeostasis (GO:0006883) | 2.73203683 |
| 164 | neuromuscular process controlling balance (GO:0050885) | 2.73039558 |
| 165 | protein localization to synapse (GO:0035418) | 2.72472713 |
| 166 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.68592866 |
| 167 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.68346907 |
| 168 | cochlea development (GO:0090102) | 2.67916716 |
| 169 | potassium ion homeostasis (GO:0055075) | 2.67086609 |
| 170 | tryptophan catabolic process (GO:0006569) | 2.65788375 |
| 171 | indole-containing compound catabolic process (GO:0042436) | 2.65788375 |
| 172 | indolalkylamine catabolic process (GO:0046218) | 2.65788375 |
| 173 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.65768419 |
| 174 | layer formation in cerebral cortex (GO:0021819) | 2.65133216 |
| 175 | positive regulation of membrane potential (GO:0045838) | 2.64176431 |
| 176 | flavonoid metabolic process (GO:0009812) | 2.62042398 |
| 177 | triglyceride homeostasis (GO:0070328) | 2.59525752 |
| 178 | acylglycerol homeostasis (GO:0055090) | 2.59525752 |
| 179 | alpha-linolenic acid metabolic process (GO:0036109) | 2.58227791 |
| 180 | regulation of postsynaptic membrane potential (GO:0060078) | 2.57815859 |
| 181 | tryptophan metabolic process (GO:0006568) | 2.53088324 |
| 182 | righting reflex (GO:0060013) | 2.53070769 |
| 183 | positive regulation of dendritic spine development (GO:0060999) | 2.52559263 |
| 184 | coenzyme catabolic process (GO:0009109) | 2.51764928 |
| 185 | proline transport (GO:0015824) | 2.50220486 |
| 186 | glutamate metabolic process (GO:0006536) | 2.49096107 |
| 187 | glycine transport (GO:0015816) | 2.48762079 |
| 188 | lipoprotein metabolic process (GO:0042157) | 2.48570708 |
| 189 | cholesterol homeostasis (GO:0042632) | 2.46328718 |
| 190 | exogenous drug catabolic process (GO:0042738) | 2.45840302 |
| 191 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.43850075 |
| 192 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.43687311 |
| 193 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.43687311 |
| 194 | bile acid metabolic process (GO:0008206) | 2.42750740 |
| 195 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.42388071 |
| 196 | long-term synaptic potentiation (GO:0060291) | 2.41370699 |
| 197 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.40655081 |
| 198 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.40655081 |
| 199 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.40280874 |
| 200 | sterol homeostasis (GO:0055092) | 2.39993319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.80912544 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.95871428 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.46517592 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.29237476 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.20145141 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06274235 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.97618830 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97202795 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.95834425 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.93536531 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88737087 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76851226 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.71492720 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66450013 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66450013 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55660363 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.54524299 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.53261743 |
| 19 | * MAF_26560356_Chip-Seq_TH1_Human | 2.50808258 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50206651 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.46391865 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46194914 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45531449 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43913450 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.43588069 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42975482 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.41879983 |
| 28 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30000726 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28067909 |
| 30 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26906245 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.25488400 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25370084 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24395081 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24385514 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18917789 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.16754609 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 2.15783880 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.14098290 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12636848 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.12430349 |
| 41 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.11507493 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10469290 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09660218 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.08946859 |
| 45 | MYB_26560356_Chip-Seq_TH2_Human | 2.07146137 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.05941015 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.04708761 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.03509766 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03214315 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02129084 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 2.00945977 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00086236 |
| 53 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99841548 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.95197883 |
| 55 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.93528054 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93334160 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89875099 |
| 58 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89660457 |
| 59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87969521 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.85303687 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81700359 |
| 62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77644085 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77589771 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77451490 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77189369 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76899523 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74031461 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73958939 |
| 69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73467550 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70270145 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66031278 |
| 72 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65115801 |
| 73 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62368383 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59775204 |
| 75 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.57324921 |
| 76 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56746576 |
| 77 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48028381 |
| 78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.47531201 |
| 79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46777339 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46692797 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.43874671 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43184502 |
| 83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41577994 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38749048 |
| 85 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37383232 |
| 86 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34927642 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33681216 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33024890 |
| 89 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.28942534 |
| 90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28657588 |
| 91 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.28221399 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27569934 |
| 93 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27439287 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27074571 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27005439 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26526299 |
| 97 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26477683 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26367162 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26175000 |
| 100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25981034 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24912200 |
| 102 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24743772 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24575329 |
| 104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23969231 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23734612 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23605117 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22382548 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21803635 |
| 109 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19859175 |
| 110 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19245830 |
| 111 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19002808 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.18563281 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17409970 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16857268 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16495968 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16277663 |
| 117 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16130487 |
| 118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14410647 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 1.11292514 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11055951 |
| 121 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10934525 |
| 122 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10200879 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09672500 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09354404 |
| 125 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08633357 |
| 126 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08513658 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08382048 |
| 128 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07756095 |
| 129 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07655298 |
| 130 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.07377515 |
| 131 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07375331 |
| 132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06882142 |
| 133 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05660240 |
| 134 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04770844 |
| 135 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04208366 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03164122 |
| 137 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03138179 |
| 138 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02897942 |
| 139 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01502726 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01191270 |
| 141 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00882645 |
| 142 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99311877 |
| 143 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99174379 |
| 144 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98976956 |
| 145 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98868665 |
| 146 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98659880 |
| 147 | AR_19668381_ChIP-Seq_PC3_Human | 0.98564051 |
| 148 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98275355 |
| 149 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96899461 |
| 150 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96708617 |
| 151 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96176412 |
| 152 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96153795 |
| 153 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95844630 |
| 154 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.95087358 |
| 155 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94722304 |
| 156 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93870897 |
| 157 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93783146 |
| 158 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92981574 |
| 159 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92006441 |
| 160 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91271990 |
| 161 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90810924 |
| 162 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89903921 |
| 163 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88011817 |
| 164 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87992904 |
| 165 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87579193 |
| 166 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87526075 |
| 167 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87360791 |
| 168 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.86560324 |
| 169 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86459943 |
| 170 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85509701 |
| 171 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85025841 |
| 172 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84212297 |
| 173 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83590300 |
| 174 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82667337 |
| 175 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82658643 |
| 176 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82426347 |
| 177 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.82142259 |
| 178 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81497234 |
| 179 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.81464540 |
| 180 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81356600 |
| 181 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81222402 |
| 182 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.81115150 |
| 183 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80289810 |
| 184 | STAT3_23295773_ChIP-Seq_U87_Human | 0.80266657 |
| 185 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.79216687 |
| 186 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.78434278 |
| 187 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.77511378 |
| 188 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77388654 |
| 189 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.76520910 |
| 190 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.76310170 |
| 191 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76130318 |
| 192 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76049845 |
| 193 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.75442891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.43985645 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.43839555 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.43197552 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.86983942 |
| 5 | MP0003436_decreased_susceptibility_to | 3.86610282 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.52210832 |
| 7 | MP0003724_increased_susceptibility_to | 3.42195077 |
| 8 | MP0000685_abnormal_immune_system | 3.28461025 |
| 9 | MP0001790_abnormal_immune_system | 3.14131238 |
| 10 | MP0005387_immune_system_phenotype | 3.14131238 |
| 11 | MP0005671_abnormal_response_to | 3.10794817 |
| 12 | MP0003763_abnormal_thymus_physiology | 3.01197707 |
| 13 | MP0003880_abnormal_central_pattern | 2.94737668 |
| 14 | MP0001800_abnormal_humoral_immune | 2.92074750 |
| 15 | MP0003252_abnormal_bile_duct | 2.90850497 |
| 16 | MP0005025_abnormal_response_to | 2.89559505 |
| 17 | MP0009785_altered_susceptibility_to | 2.86860015 |
| 18 | MP0003303_peritoneal_inflammation | 2.85822176 |
| 19 | MP0004270_analgesia | 2.79348223 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.76506912 |
| 21 | MP0005083_abnormal_biliary_tract | 2.76142664 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 2.74851651 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.73580839 |
| 24 | MP0005365_abnormal_bile_salt | 2.68677291 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 2.63085549 |
| 26 | MP0002419_abnormal_innate_immunity | 2.59584830 |
| 27 | MP0002723_abnormal_immune_serum | 2.52791243 |
| 28 | MP0010329_abnormal_lipoprotein_level | 2.51616196 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.45120901 |
| 30 | MP0002420_abnormal_adaptive_immunity | 2.42646512 |
| 31 | MP0001819_abnormal_immune_cell | 2.40865719 |
| 32 | MP0003300_gastrointestinal_ulcer | 2.34486131 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 2.34267299 |
| 34 | MP0009046_muscle_twitch | 2.32884794 |
| 35 | MP0006082_CNS_inflammation | 2.32815381 |
| 36 | MP0005377_hearing/vestibular/ear_phenot | 2.24352852 |
| 37 | MP0003878_abnormal_ear_physiology | 2.24352852 |
| 38 | MP0009745_abnormal_behavioral_response | 2.23232095 |
| 39 | MP0001486_abnormal_startle_reflex | 2.21439487 |
| 40 | MP0003879_abnormal_hair_cell | 2.17376585 |
| 41 | MP0001968_abnormal_touch/_nociception | 2.16977718 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 2.09130527 |
| 43 | MP0003329_amyloid_beta_deposits | 2.08699023 |
| 44 | MP0004947_skin_inflammation | 2.07624671 |
| 45 | MP0010155_abnormal_intestine_physiology | 2.07369665 |
| 46 | MP0002064_seizures | 2.03098292 |
| 47 | MP0004381_abnormal_hair_follicle | 2.01118268 |
| 48 | MP0002398_abnormal_bone_marrow | 1.99985468 |
| 49 | MP0002063_abnormal_learning/memory/cond | 1.98843685 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.97884726 |
| 51 | MP0001485_abnormal_pinna_reflex | 1.97232762 |
| 52 | MP0001873_stomach_inflammation | 1.95582239 |
| 53 | MP0002405_respiratory_system_inflammati | 1.94764113 |
| 54 | MP0000716_abnormal_immune_system | 1.92722856 |
| 55 | MP0002272_abnormal_nervous_system | 1.90948256 |
| 56 | MP0009379_abnormal_foot_pigmentation | 1.89824095 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.87052152 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.86737256 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.82549630 |
| 60 | MP0002822_catalepsy | 1.82115870 |
| 61 | MP0002572_abnormal_emotion/affect_behav | 1.81962297 |
| 62 | MP0003866_abnormal_defecation | 1.81053237 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 1.78214225 |
| 64 | MP0002736_abnormal_nociception_after | 1.77188722 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.75168508 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.74568335 |
| 67 | MP0008260_abnormal_autophagy | 1.73491196 |
| 68 | MP0000858_altered_metastatic_potential | 1.73225767 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.63495140 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.61275325 |
| 71 | MP0009278_abnormal_bone_marrow | 1.60886173 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.59438306 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.58837991 |
| 74 | MP0004885_abnormal_endolymph | 1.58024051 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.56981004 |
| 76 | MP0002184_abnormal_innervation | 1.56126793 |
| 77 | MP0002429_abnormal_blood_cell | 1.55645610 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 1.54817153 |
| 79 | MP0001851_eye_inflammation | 1.54325132 |
| 80 | MP0002722_abnormal_immune_system | 1.53765389 |
| 81 | MP0005451_abnormal_body_composition | 1.52829812 |
| 82 | MP0001346_abnormal_lacrimal_gland | 1.50982491 |
| 83 | MP0005310_abnormal_salivary_gland | 1.49400694 |
| 84 | MP0001440_abnormal_grooming_behavior | 1.48161086 |
| 85 | MP0000689_abnormal_spleen_morphology | 1.45500865 |
| 86 | MP0009840_abnormal_foam_cell | 1.42602575 |
| 87 | MP0004510_myositis | 1.42521811 |
| 88 | MP0000604_amyloidosis | 1.41987051 |
| 89 | MP0010368_abnormal_lymphatic_system | 1.40917077 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 1.40467990 |
| 91 | MP0002796_impaired_skin_barrier | 1.39559248 |
| 92 | MP0005423_abnormal_somatic_nervous | 1.38658533 |
| 93 | MP0003172_abnormal_lysosome_physiology | 1.37443351 |
| 94 | MP0002735_abnormal_chemical_nociception | 1.36413325 |
| 95 | MP0008569_lethality_at_weaning | 1.35787093 |
| 96 | MP0008469_abnormal_protein_level | 1.34594914 |
| 97 | MP0005623_abnormal_meninges_morphology | 1.34163365 |
| 98 | MP0002102_abnormal_ear_morphology | 1.34133845 |
| 99 | MP0002067_abnormal_sensory_capabilities | 1.33868895 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 1.30851696 |
| 101 | MP0005058_abnormal_lysosome_morphology | 1.23828485 |
| 102 | MP0004019_abnormal_vitamin_homeostasis | 1.23634915 |
| 103 | MP0002254_reproductive_system_inflammat | 1.23549068 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 1.19795508 |
| 105 | MP0004742_abnormal_vestibular_system | 1.19122662 |
| 106 | MP0001502_abnormal_circadian_rhythm | 1.18490559 |
| 107 | MP0002006_tumorigenesis | 1.17326839 |
| 108 | MP0003045_fibrosis | 1.15954867 |
| 109 | MP0003705_abnormal_hypodermis_morpholog | 1.15419627 |
| 110 | MP0003938_abnormal_ear_development | 1.14495918 |
| 111 | MP0005332_abnormal_amino_acid | 1.13787595 |
| 112 | MP0002557_abnormal_social/conspecific_i | 1.12619168 |
| 113 | MP0003566_abnormal_cell_adhesion | 1.11851019 |
| 114 | MP0004142_abnormal_muscle_tone | 1.11422101 |
| 115 | MP0001963_abnormal_hearing_physiology | 1.11314365 |
| 116 | MP0005397_hematopoietic_system_phenotyp | 1.11171842 |
| 117 | MP0001545_abnormal_hematopoietic_system | 1.11171842 |
| 118 | MP0002733_abnormal_thermal_nociception | 1.10248094 |
| 119 | MP0003448_altered_tumor_morphology | 1.09966932 |
| 120 | MP0005076_abnormal_cell_differentiation | 1.09898618 |
| 121 | MP0002277_abnormal_respiratory_mucosa | 1.07630008 |
| 122 | MP0003828_pulmonary_edema | 1.07255545 |
| 123 | MP0000955_abnormal_spinal_cord | 1.06540035 |
| 124 | MP0005448_abnormal_energy_balance | 1.06149607 |
| 125 | MP0000579_abnormal_nail_morphology | 1.05975660 |
| 126 | MP0000026_abnormal_inner_ear | 1.04781924 |
| 127 | MP0001216_abnormal_epidermal_layer | 1.04078893 |
| 128 | MP0002132_abnormal_respiratory_system | 1.03734057 |
| 129 | MP0001853_heart_inflammation | 1.02596556 |
| 130 | MP0002933_joint_inflammation | 1.01380625 |
| 131 | MP0001188_hyperpigmentation | 1.01265285 |
| 132 | MP0000490_abnormal_crypts_of | 1.00583748 |
| 133 | MP0000778_abnormal_nervous_system | 0.98298599 |
| 134 | MP0002066_abnormal_motor_capabilities/c | 0.97496924 |
| 135 | MP0001970_abnormal_pain_threshold | 0.97044918 |
| 136 | MP0004858_abnormal_nervous_system | 0.95793415 |
| 137 | MP0003690_abnormal_glial_cell | 0.93865225 |
| 138 | MP0003091_abnormal_cell_migration | 0.92989853 |
| 139 | MP0002998_abnormal_bone_remodeling | 0.91377578 |
| 140 | MP0004264_abnormal_extraembryonic_tissu | 0.90913136 |
| 141 | MP0009764_decreased_sensitivity_to | 0.89706385 |
| 142 | MP0004808_abnormal_hematopoietic_stem | 0.89616884 |
| 143 | MP0008961_abnormal_basal_metabolism | 0.89041621 |
| 144 | MP0005166_decreased_susceptibility_to | 0.88864939 |
| 145 | MP0005075_abnormal_melanosome_morpholog | 0.88821410 |
| 146 | MP0008874_decreased_physiological_sensi | 0.87191096 |
| 147 | MP0004043_abnormal_pH_regulation | 0.86644993 |
| 148 | MP0005535_abnormal_body_temperature | 0.86644363 |
| 149 | MP0002882_abnormal_neuron_morphology | 0.84298988 |
| 150 | MP0004085_abnormal_heartbeat | 0.84258180 |
| 151 | MP0005501_abnormal_skin_physiology | 0.83537155 |
| 152 | MP0003122_maternal_imprinting | 0.83056588 |
| 153 | MP0002138_abnormal_hepatobiliary_system | 0.81767681 |
| 154 | MP0009931_abnormal_skin_appearance | 0.81655656 |
| 155 | MP0005390_skeleton_phenotype | 0.81614513 |
| 156 | MP0003632_abnormal_nervous_system | 0.81061984 |
| 157 | MP0003868_abnormal_feces_composition | 0.80534916 |
| 158 | MP0001663_abnormal_digestive_system | 0.80470081 |
| 159 | MP0009763_increased_sensitivity_to | 0.79763422 |
| 160 | MP0002971_abnormal_brown_adipose | 0.79544542 |
| 161 | MP0004883_abnormal_blood_vessel | 0.78882797 |
| 162 | MP0002069_abnormal_eating/drinking_beha | 0.77636320 |
| 163 | MP0001348_abnormal_lacrimal_gland | 0.77552803 |
| 164 | MP0000427_abnormal_hair_cycle | 0.76189616 |
| 165 | MP0009384_cardiac_valve_regurgitation | 0.75983497 |
| 166 | MP0001664_abnormal_digestion | 0.75725822 |
| 167 | MP0005023_abnormal_wound_healing | 0.74099403 |
| 168 | MP0002060_abnormal_skin_morphology | 0.74088898 |
| 169 | MP0003183_abnormal_peptide_metabolism | 0.74065406 |
| 170 | MP0004811_abnormal_neuron_physiology | 0.72980438 |
| 171 | MP0002089_abnormal_postnatal_growth/wei | 0.72213537 |
| 172 | MP0001765_abnormal_ion_homeostasis | 0.72133033 |
| 173 | MP0002019_abnormal_tumor_incidence | 0.70914470 |
| 174 | MP0004185_abnormal_adipocyte_glucose | 0.69966349 |
| 175 | MP0002909_abnormal_adrenal_gland | 0.69717255 |
| 176 | MP0000377_abnormal_hair_follicle | 0.69503401 |
| 177 | MP0000678_abnormal_parathyroid_gland | 0.69342821 |
| 178 | MP0000609_abnormal_liver_physiology | 0.68409227 |
| 179 | MP0002928_abnormal_bile_duct | 0.68115008 |
| 180 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67154008 |
| 181 | MP0002229_neurodegeneration | 0.66620138 |
| 182 | MP0002877_abnormal_melanocyte_morpholog | 0.65484720 |
| 183 | MP0000534_abnormal_ureter_morphology | 0.63284365 |
| 184 | MP0005164_abnormal_response_to | 0.62804234 |
| 185 | MP0008872_abnormal_physiological_respon | 0.62345412 |
| 186 | MP0000462_abnormal_digestive_system | 0.61885491 |
| 187 | MP0003075_altered_response_to | 0.61103350 |
| 188 | MP0002876_abnormal_thyroid_physiology | 0.60184237 |
| 189 | MP0003795_abnormal_bone_structure | 0.60097255 |
| 190 | MP0003631_nervous_system_phenotype | 0.59122280 |
| 191 | MP0002752_abnormal_somatic_nervous | 0.58926183 |
| 192 | MP0000343_altered_response_to | 0.58848781 |
| 193 | MP0005621_abnormal_cell_physiology | 0.58846686 |
| 194 | MP0004924_abnormal_behavior | 0.58674944 |
| 195 | MP0005386_behavior/neurological_phenoty | 0.58674944 |
| 196 | MP0000639_abnormal_adrenal_gland | 0.56532575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.65025315 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 5.41914017 |
| 3 | Myositis (HP:0100614) | 4.65312549 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.56078356 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.49584935 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.37887422 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.35906388 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.32095347 |
| 9 | Increased IgE level (HP:0003212) | 4.26452138 |
| 10 | Orchitis (HP:0100796) | 4.22961743 |
| 11 | Focal motor seizures (HP:0011153) | 4.22327770 |
| 12 | Potter facies (HP:0002009) | 4.21106659 |
| 13 | Facial shape deformation (HP:0011334) | 4.21106659 |
| 14 | Focal seizures (HP:0007359) | 4.20494801 |
| 15 | Xanthomatosis (HP:0000991) | 4.03391634 |
| 16 | Deep venous thrombosis (HP:0002625) | 4.03276375 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.92301514 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.88613520 |
| 19 | Myokymia (HP:0002411) | 3.86302356 |
| 20 | Visual hallucinations (HP:0002367) | 3.84460458 |
| 21 | Optic neuritis (HP:0100653) | 3.82489659 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.82489659 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.81615213 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.72770713 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.71116857 |
| 26 | Meningitis (HP:0001287) | 3.70183236 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.59928720 |
| 28 | Obstructive lung disease (HP:0006536) | 3.59928720 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50545679 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50545679 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.48882077 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.47596363 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.47195092 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.42426416 |
| 35 | Action tremor (HP:0002345) | 3.39703785 |
| 36 | Stomatitis (HP:0010280) | 3.36842590 |
| 37 | Recurrent viral infections (HP:0004429) | 3.36726586 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.34400995 |
| 39 | Vasculitis (HP:0002633) | 3.31507559 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 3.20217665 |
| 41 | Prolonged partial thromboplastin time (HP:0003645) | 3.20147513 |
| 42 | Recurrent skin infections (HP:0001581) | 3.18390200 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.17809398 |
| 44 | Acanthocytosis (HP:0001927) | 3.17510900 |
| 45 | Cellulitis (HP:0100658) | 3.17339990 |
| 46 | Spontaneous abortion (HP:0005268) | 3.16526410 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 3.10725744 |
| 48 | Inflammation of the large intestine (HP:0002037) | 3.08548763 |
| 49 | Ventricular fibrillation (HP:0001663) | 3.04281665 |
| 50 | Epileptic encephalopathy (HP:0200134) | 2.99749526 |
| 51 | Gingivitis (HP:0000230) | 2.99599355 |
| 52 | Urticaria (HP:0001025) | 2.97466382 |
| 53 | Intention tremor (HP:0002080) | 2.96539031 |
| 54 | Encephalitis (HP:0002383) | 2.95174061 |
| 55 | Hyperglycinuria (HP:0003108) | 2.90953691 |
| 56 | Chronic otitis media (HP:0000389) | 2.88408001 |
| 57 | Agammaglobulinemia (HP:0004432) | 2.87858382 |
| 58 | Progressive cerebellar ataxia (HP:0002073) | 2.85894413 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.85787752 |
| 60 | Epidermoid cyst (HP:0200040) | 2.85561560 |
| 61 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.83431361 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.82567743 |
| 63 | Poikilocytosis (HP:0004447) | 2.80808399 |
| 64 | Milia (HP:0001056) | 2.80402823 |
| 65 | Confusion (HP:0001289) | 2.78336263 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.76587209 |
| 67 | Chest pain (HP:0100749) | 2.73595643 |
| 68 | Pustule (HP:0200039) | 2.73191356 |
| 69 | Hypochromic microcytic anemia (HP:0004840) | 2.72997154 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 2.72667498 |
| 71 | Fat malabsorption (HP:0002630) | 2.71940694 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.71377959 |
| 73 | Cholecystitis (HP:0001082) | 2.71377959 |
| 74 | Hypercholesterolemia (HP:0003124) | 2.69218511 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 2.68265742 |
| 76 | Status epilepticus (HP:0002133) | 2.67371528 |
| 77 | Hyperlipoproteinemia (HP:0010980) | 2.67018775 |
| 78 | Polygenic inheritance (HP:0010982) | 2.64746697 |
| 79 | Hemoptysis (HP:0002105) | 2.64731049 |
| 80 | Skin ulcer (HP:0200042) | 2.63681331 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 2.62999561 |
| 82 | Hypochromic anemia (HP:0001931) | 2.62414751 |
| 83 | Thick nail (HP:0001805) | 2.62405699 |
| 84 | Autoimmune hemolytic anemia (HP:0001890) | 2.61520322 |
| 85 | Increased IgM level (HP:0003496) | 2.61470038 |
| 86 | Spontaneous hematomas (HP:0007420) | 2.60978385 |
| 87 | Torticollis (HP:0000473) | 2.60881205 |
| 88 | Nasal polyposis (HP:0100582) | 2.60158988 |
| 89 | Prolonged bleeding time (HP:0003010) | 2.57136510 |
| 90 | Hydroxyprolinuria (HP:0003080) | 2.57079417 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.57079417 |
| 92 | Abnormality of glycine metabolism (HP:0010895) | 2.54907340 |
| 93 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.54907340 |
| 94 | Febrile seizures (HP:0002373) | 2.54098358 |
| 95 | Joint hemorrhage (HP:0005261) | 2.53904688 |
| 96 | Granulocytopenia (HP:0001913) | 2.53348780 |
| 97 | Generalized tonic-clonic seizures (HP:0002069) | 2.51042873 |
| 98 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48781293 |
| 99 | Reticulocytosis (HP:0001923) | 2.46446821 |
| 100 | Ketoacidosis (HP:0001993) | 2.45395009 |
| 101 | Malnutrition (HP:0004395) | 2.45047804 |
| 102 | Osteomyelitis (HP:0002754) | 2.44060462 |
| 103 | Complement deficiency (HP:0004431) | 2.43359446 |
| 104 | Abnormal eating behavior (HP:0100738) | 2.43147743 |
| 105 | Keratoconjunctivitis (HP:0001096) | 2.42962009 |
| 106 | Abnormality of the lower motor neuron (HP:0002366) | 2.42244119 |
| 107 | Abnormal social behavior (HP:0012433) | 2.39860237 |
| 108 | Impaired social interactions (HP:0000735) | 2.39860237 |
| 109 | Abnormality of T cells (HP:0002843) | 2.38794473 |
| 110 | Hypoalphalipoproteinemia (HP:0003233) | 2.37290049 |
| 111 | Ketosis (HP:0001946) | 2.36029210 |
| 112 | Sepsis (HP:0100806) | 2.34871131 |
| 113 | Absence seizures (HP:0002121) | 2.34763767 |
| 114 | Cerebral inclusion bodies (HP:0100314) | 2.34464622 |
| 115 | Abnormality of the corticospinal tract (HP:0002492) | 2.33857420 |
| 116 | Neurofibrillary tangles (HP:0002185) | 2.33646246 |
| 117 | T lymphocytopenia (HP:0005403) | 2.32627923 |
| 118 | Petechiae (HP:0000967) | 2.31601391 |
| 119 | Lip pit (HP:0100267) | 2.30192511 |
| 120 | Loss of speech (HP:0002371) | 2.29796498 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 2.29674085 |
| 122 | Dysdiadochokinesis (HP:0002075) | 2.29365885 |
| 123 | Lymphopenia (HP:0001888) | 2.29045033 |
| 124 | Premature loss of primary teeth (HP:0006323) | 2.28958167 |
| 125 | Epistaxis (HP:0000421) | 2.25540672 |
| 126 | Increased circulating renin level (HP:0000848) | 2.25267168 |
| 127 | Abnormality of T cell physiology (HP:0011840) | 2.24637905 |
| 128 | Recurrent corneal erosions (HP:0000495) | 2.24297331 |
| 129 | Hyperammonemia (HP:0001987) | 2.23839895 |
| 130 | Ileus (HP:0002595) | 2.21228576 |
| 131 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.20459799 |
| 132 | Atonic seizures (HP:0010819) | 2.19431411 |
| 133 | Chorioretinal atrophy (HP:0000533) | 2.18735857 |
| 134 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18724099 |
| 135 | Prolonged QT interval (HP:0001657) | 2.18623252 |
| 136 | Abnormality of T cell number (HP:0011839) | 2.18419846 |
| 137 | Abnormality of the nasal mucosa (HP:0000433) | 2.18328596 |
| 138 | Abnormal gallbladder morphology (HP:0012437) | 2.18312237 |
| 139 | Syncope (HP:0001279) | 2.18279634 |
| 140 | Cholelithiasis (HP:0001081) | 2.18134449 |
| 141 | Leukocytosis (HP:0001974) | 2.18118370 |
| 142 | Skin rash (HP:0000988) | 2.17947758 |
| 143 | Cheilitis (HP:0100825) | 2.14952773 |
| 144 | Annular pancreas (HP:0001734) | 2.13566446 |
| 145 | Focal dystonia (HP:0004373) | 2.13339726 |
| 146 | Arterial thrombosis (HP:0004420) | 2.12648380 |
| 147 | Neonatal onset (HP:0003623) | 2.11920523 |
| 148 | Abnormality of methionine metabolism (HP:0010901) | 2.11585290 |
| 149 | Postural instability (HP:0002172) | 2.11393961 |
| 150 | Craniofacial dystonia (HP:0012179) | 2.11072144 |
| 151 | Episodic fever (HP:0001954) | 2.10200614 |
| 152 | Abnormal blistering of the skin (HP:0008066) | 2.09439043 |
| 153 | Interstitial pulmonary disease (HP:0006530) | 2.09275212 |
| 154 | Hypertensive crisis (HP:0100735) | 2.06445701 |
| 155 | Skin nodule (HP:0200036) | 2.04986640 |
| 156 | Scanning speech (HP:0002168) | 2.04929958 |
| 157 | Anorexia (HP:0002039) | 2.03355421 |
| 158 | Abnormality of the pleura (HP:0002103) | 2.02946224 |
| 159 | IgM deficiency (HP:0002850) | 2.02348022 |
| 160 | Poor eye contact (HP:0000817) | 2.02277266 |
| 161 | Pulmonary embolism (HP:0002204) | 2.00354478 |
| 162 | Dysmetria (HP:0001310) | 1.99333591 |
| 163 | Restrictive lung disease (HP:0002091) | 1.99157306 |
| 164 | Gingival bleeding (HP:0000225) | 1.98762668 |
| 165 | Papilloma (HP:0012740) | 1.98752621 |
| 166 | Verrucae (HP:0200043) | 1.98752621 |
| 167 | Emphysema (HP:0002097) | 1.98574979 |
| 168 | Dialeptic seizures (HP:0011146) | 1.97188488 |
| 169 | Increased cerebral lipofuscin (HP:0011813) | 1.96926261 |
| 170 | Abnormality of the pericardium (HP:0001697) | 1.95284396 |
| 171 | Stereotypic behavior (HP:0000733) | 1.95107151 |
| 172 | Viral hepatitis (HP:0006562) | 1.93853799 |
| 173 | Late onset (HP:0003584) | 1.93767415 |
| 174 | Gangrene (HP:0100758) | 1.93605665 |
| 175 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92733790 |
| 176 | Hemiplegia (HP:0002301) | 1.92201158 |
| 177 | Nail dystrophy (HP:0008404) | 1.91194206 |
| 178 | Tetraplegia (HP:0002445) | 1.90409363 |
| 179 | Increased serum ferritin (HP:0003281) | 1.90397423 |
| 180 | Microcytic anemia (HP:0001935) | 1.90160976 |
| 181 | Hyperbilirubinemia (HP:0002904) | 1.89168161 |
| 182 | Metaphyseal cupping (HP:0003021) | 1.89053696 |
| 183 | Growth hormone excess (HP:0000845) | 1.88417191 |
| 184 | Abnormality of the salivary glands (HP:0010286) | 1.88026002 |
| 185 | Colitis (HP:0002583) | 1.87371826 |
| 186 | Plantar hyperkeratosis (HP:0007556) | 1.86926360 |
| 187 | Hyperkalemia (HP:0002153) | 1.85896941 |
| 188 | Purpura (HP:0000979) | 1.84778847 |
| 189 | Abnormality of the fingertips (HP:0001211) | 1.84750708 |
| 190 | Metabolic acidosis (HP:0001942) | 1.84219073 |
| 191 | Sensorimotor neuropathy (HP:0007141) | 1.83021493 |
| 192 | Anxiety (HP:0000739) | 1.82171081 |
| 193 | Broad-based gait (HP:0002136) | 1.80722449 |
| 194 | Pigmentary retinal degeneration (HP:0001146) | 1.80239086 |
| 195 | Ankle clonus (HP:0011448) | 1.79388573 |
| 196 | Bundle branch block (HP:0011710) | 1.78393334 |
| 197 | Spastic gait (HP:0002064) | 1.76093026 |
| 198 | Gout (HP:0001997) | 1.75307864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.97634414 |
| 2 | MAP4K1 | 4.24557209 |
| 3 | SIK3 | 4.13046215 |
| 4 | NTRK3 | 3.77011154 |
| 5 | ERN1 | 3.73438695 |
| 6 | MAP3K13 | 3.31851873 |
| 7 | TYK2 | 3.17783027 |
| 8 | SIK2 | 2.96972404 |
| 9 | PAK6 | 2.73736790 |
| 10 | ARAF | 2.68559236 |
| 11 | SIK1 | 2.59942540 |
| 12 | TNIK | 2.49329385 |
| 13 | EPHA4 | 2.31244706 |
| 14 | BLK | 2.19792521 |
| 15 | TRIB3 | 2.17696361 |
| 16 | IRAK4 | 2.15707717 |
| 17 | TNK2 | 2.12555877 |
| 18 | SMG1 | 2.07065747 |
| 19 | JAK3 | 2.06693176 |
| 20 | KSR2 | 2.04622603 |
| 21 | IKBKE | 2.00924675 |
| 22 | FGFR4 | 1.97899802 |
| 23 | DDR2 | 1.95649435 |
| 24 | DAPK2 | 1.91217082 |
| 25 | CSK | 1.90445990 |
| 26 | TBK1 | 1.87959888 |
| 27 | JAK1 | 1.87294303 |
| 28 | ZAP70 | 1.81923888 |
| 29 | MAP2K3 | 1.81154024 |
| 30 | NTRK2 | 1.80541191 |
| 31 | MAP3K3 | 1.74634241 |
| 32 | MAP3K14 | 1.74210566 |
| 33 | PRPF4B | 1.65237493 |
| 34 | FGR | 1.61112974 |
| 35 | UHMK1 | 1.59672544 |
| 36 | BTK | 1.57640133 |
| 37 | KIT | 1.56493317 |
| 38 | MINK1 | 1.43261411 |
| 39 | PTK2B | 1.42085634 |
| 40 | RIPK4 | 1.37613815 |
| 41 | MAP3K11 | 1.33554656 |
| 42 | RIPK1 | 1.31643909 |
| 43 | HIPK2 | 1.30880585 |
| 44 | TXK | 1.30557068 |
| 45 | HCK | 1.28189389 |
| 46 | FRK | 1.24136076 |
| 47 | SYK | 1.21974768 |
| 48 | KSR1 | 1.20868114 |
| 49 | FGFR3 | 1.19566130 |
| 50 | PAK3 | 1.18704780 |
| 51 | CDK12 | 1.16365077 |
| 52 | TESK2 | 1.16226269 |
| 53 | NME2 | 1.13376188 |
| 54 | NTRK1 | 1.13094772 |
| 55 | MAP3K6 | 1.11019513 |
| 56 | PRKD2 | 1.10715037 |
| 57 | LCK | 1.10606663 |
| 58 | MAP2K4 | 1.09691413 |
| 59 | IKBKB | 1.07887029 |
| 60 | MARK2 | 1.07037143 |
| 61 | MARK1 | 1.06505544 |
| 62 | AKT3 | 1.04124293 |
| 63 | CDK5 | 1.00997567 |
| 64 | JAK2 | 1.00730935 |
| 65 | LYN | 1.00579721 |
| 66 | EPHA2 | 1.00451970 |
| 67 | CSF1R | 0.99102349 |
| 68 | CAMK1 | 0.93735091 |
| 69 | GRK5 | 0.93371666 |
| 70 | FES | 0.92960855 |
| 71 | GRK6 | 0.92255185 |
| 72 | IRAK3 | 0.88747744 |
| 73 | PRKCG | 0.88532052 |
| 74 | STK16 | 0.87248441 |
| 75 | GRK1 | 0.87227400 |
| 76 | EPHA3 | 0.85580132 |
| 77 | ITK | 0.85173657 |
| 78 | IRAK2 | 0.84310476 |
| 79 | MAP3K4 | 0.83170042 |
| 80 | CAMK2G | 0.80535927 |
| 81 | TESK1 | 0.80466003 |
| 82 | CDK19 | 0.80013023 |
| 83 | PDPK1 | 0.79861840 |
| 84 | SGK494 | 0.79149734 |
| 85 | SGK223 | 0.79149734 |
| 86 | CAMK2B | 0.79114636 |
| 87 | EPHB1 | 0.78577201 |
| 88 | PKN1 | 0.77791014 |
| 89 | MAP3K10 | 0.77759245 |
| 90 | MAPK15 | 0.77611098 |
| 91 | PTK2 | 0.77215710 |
| 92 | PAK2 | 0.76641630 |
| 93 | IRAK1 | 0.74126455 |
| 94 | LMTK2 | 0.73919492 |
| 95 | CAMK2A | 0.73460053 |
| 96 | PTK6 | 0.72912459 |
| 97 | MAP3K1 | 0.72599965 |
| 98 | MST1R | 0.72218774 |
| 99 | CDC42BPA | 0.71676735 |
| 100 | CDK18 | 0.70487883 |
| 101 | MAPK13 | 0.70184042 |
| 102 | MARK3 | 0.69995006 |
| 103 | CASK | 0.69938857 |
| 104 | TAOK2 | 0.68898741 |
| 105 | PRKCH | 0.68852789 |
| 106 | MAPK7 | 0.67511336 |
| 107 | CDK15 | 0.67487709 |
| 108 | MAP3K7 | 0.67154050 |
| 109 | SGK2 | 0.65378265 |
| 110 | ICK | 0.65091654 |
| 111 | CAMK4 | 0.64986307 |
| 112 | BRAF | 0.64016649 |
| 113 | LRRK2 | 0.63960616 |
| 114 | ERBB3 | 0.63521380 |
| 115 | PDK1 | 0.61375718 |
| 116 | MAP2K6 | 0.60225953 |
| 117 | STK11 | 0.60044660 |
| 118 | NME1 | 0.59793262 |
| 119 | CDK14 | 0.59300886 |
| 120 | PHKG2 | 0.58944503 |
| 121 | PHKG1 | 0.58944503 |
| 122 | BCR | 0.57709516 |
| 123 | CAMKK1 | 0.57537931 |
| 124 | ADRBK2 | 0.57406453 |
| 125 | CDK4 | 0.57010395 |
| 126 | MAP2K1 | 0.56605323 |
| 127 | MAPK11 | 0.56315191 |
| 128 | TAOK3 | 0.56156430 |
| 129 | CAMKK2 | 0.56137368 |
| 130 | MAPKAPK2 | 0.56115689 |
| 131 | OXSR1 | 0.56092731 |
| 132 | CHUK | 0.55870240 |
| 133 | DYRK1A | 0.55520843 |
| 134 | CDK11A | 0.54658299 |
| 135 | TEC | 0.53306601 |
| 136 | BMX | 0.52906867 |
| 137 | STK10 | 0.52501128 |
| 138 | INSRR | 0.51776312 |
| 139 | TAOK1 | 0.51677404 |
| 140 | STK38 | 0.51489025 |
| 141 | MOS | 0.51207573 |
| 142 | MAP3K2 | 0.50982195 |
| 143 | MET | 0.50936773 |
| 144 | ADRBK1 | 0.50429971 |
| 145 | SGK3 | 0.49884303 |
| 146 | PRKCZ | 0.49884014 |
| 147 | FER | 0.49769407 |
| 148 | ERBB2 | 0.49676927 |
| 149 | RET | 0.48952334 |
| 150 | FYN | 0.48657908 |
| 151 | NLK | 0.47981020 |
| 152 | PRKD3 | 0.47040083 |
| 153 | PKN2 | 0.46928291 |
| 154 | ERBB4 | 0.45545231 |
| 155 | PRKCE | 0.44069132 |
| 156 | MATK | 0.43845279 |
| 157 | MAPK12 | 0.43490597 |
| 158 | CAMK2D | 0.43193252 |
| 159 | DYRK1B | 0.43155505 |
| 160 | MAP2K7 | 0.42757973 |
| 161 | YES1 | 0.41092168 |
| 162 | PRKCQ | 0.38421560 |
| 163 | RPS6KC1 | 0.38400763 |
| 164 | RPS6KL1 | 0.38400763 |
| 165 | MAP2K2 | 0.33580571 |
| 166 | KDR | 0.33416091 |
| 167 | CDK9 | 0.28464378 |
| 168 | MAPK3 | 0.28015151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.89298842 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.85514112 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.75948494 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.73925210 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.71905674 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.64629076 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64033804 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.61775069 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51318142 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.33189308 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.29084507 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25718458 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.23279038 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21740407 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.18447674 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.17040411 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 2.14262112 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13822424 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04384323 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 2.03560550 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01749813 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99843910 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.96607454 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.95182018 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.91890212 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.85202486 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83404571 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82099054 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81834877 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75076155 |
| 31 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.74395072 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74275908 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.72525717 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70294063 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.66948835 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.65728288 |
| 37 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.62682986 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.62128682 |
| 39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.61990092 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.60192846 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.55983164 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.53900057 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 1.51501396 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.49887731 |
| 45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48970752 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46550987 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45123824 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.44751548 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.43806923 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43000036 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42515062 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41075417 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39730502 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38774272 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37605177 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35800874 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.35562173 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35527512 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35442522 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.34448203 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.34326928 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34308481 |
| 63 | Olfactory transduction_Homo sapiens_hsa04740 | 1.33182285 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.32790894 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31295469 |
| 66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30375617 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 1.30230010 |
| 68 | Morphine addiction_Homo sapiens_hsa05032 | 1.26502572 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25599176 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25526328 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.25500041 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.25129534 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 1.24323105 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23323050 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21715148 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19766063 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 1.18265191 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15554700 |
| 79 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14884870 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13913441 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13802158 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12794669 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11829076 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08768562 |
| 85 | Taste transduction_Homo sapiens_hsa04742 | 1.08454942 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08261725 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.07889920 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07316576 |
| 89 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05115321 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 1.04241314 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 1.02274591 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 1.02260260 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 1.01873112 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00431203 |
| 95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.99743821 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.99368723 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.97981870 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.97890003 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97798459 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97414419 |
| 101 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.97221028 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93314665 |
| 103 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90485157 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90078579 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89852267 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87616837 |
| 107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87317645 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85414893 |
| 109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84906367 |
| 110 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84573767 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.84387674 |
| 112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.83663717 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83044479 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82726486 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.82586148 |
| 116 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81574451 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81205578 |
| 118 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81170639 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80683096 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.80125461 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80091662 |
| 122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79744810 |
| 123 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79522314 |
| 124 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79445644 |
| 125 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77836384 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.76288753 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76109132 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75165461 |
| 129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75039143 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74647549 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73929829 |
| 132 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72804479 |
| 133 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72438407 |
| 134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72139351 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71502711 |
| 136 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71446333 |
| 137 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71133500 |
| 138 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69920009 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68505386 |
| 140 | Peroxisome_Homo sapiens_hsa04146 | 0.68481217 |
| 141 | Gap junction_Homo sapiens_hsa04540 | 0.68089046 |
| 142 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68025911 |
| 143 | Axon guidance_Homo sapiens_hsa04360 | 0.67496615 |
| 144 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67284151 |
| 145 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66599326 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.66592740 |
| 147 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65934352 |
| 148 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64016947 |
| 149 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63668475 |
| 150 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63304212 |
| 151 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62788052 |
| 152 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62582948 |
| 153 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60314767 |
| 154 | Amoebiasis_Homo sapiens_hsa05146 | 0.58450757 |
| 155 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58186604 |
| 156 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58058324 |
| 157 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57912005 |
| 158 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57345637 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57247623 |
| 160 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56471073 |
| 161 | Lysosome_Homo sapiens_hsa04142 | 0.56325030 |
| 162 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56024096 |
| 163 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55979556 |
| 164 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55806273 |
| 165 | Melanogenesis_Homo sapiens_hsa04916 | 0.55757775 |
| 166 | Insulin resistance_Homo sapiens_hsa04931 | 0.55117089 |
| 167 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54321302 |
| 168 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54280938 |
| 169 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53896036 |
| 170 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53322660 |
| 171 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53251194 |
| 172 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52893360 |
| 173 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52711209 |
| 174 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52112852 |
| 175 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51684568 |
| 176 | Prion diseases_Homo sapiens_hsa05020 | 0.51531833 |
| 177 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51455100 |
| 178 | Glioma_Homo sapiens_hsa05214 | 0.51102748 |
| 179 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51096192 |
| 180 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50416303 |
| 181 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50337753 |
| 182 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48241416 |
| 183 | Prostate cancer_Homo sapiens_hsa05215 | 0.47502024 |
| 184 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46156234 |
| 185 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45995110 |
| 186 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45516400 |
| 187 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44911256 |
| 188 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43582612 |
| 189 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42411443 |
| 190 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41013245 |
| 191 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38484673 |
| 192 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37634390 |
| 193 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35794991 |
| 194 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35030710 |
| 195 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32917777 |

